Latest National Holdings (NHLD) Headlines Nep
Post# of 15
Neptune Announces Closing of the Over-Allotment Option Associated with its Recently Completed Public Offering of Common Shares
PR Newswire - Thu Mar 06, 10:53AM CST
Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.NTB), announced today that the syndicate of underwriters led by of Euro Pacific Canada Inc. and Roth Capital Partners, as Joint Book-Running Managers, and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD) as Lead Manager, have exercised in full the over-allotment option to purchase an additional 1,500,000 common shares of Neptune at a price of US$2.50 per common share in connection with Neptune's previously announced public offering, completed on March 5, 2014. As a result of the exercise of the over-allotment option, Neptune received additional gross proceeds of US$3.75 million for total gross proceeds of US$28.75 million.
Iroquois Capital Delivers Letter to National Holdings Corporation
PR Newswire - Thu Mar 06, 7:12AM CST
Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest shareholders of National Holdings Corporation ("OTC BB: NHLD" or the "Company") with beneficial ownership of approximately 5.9% of the outstanding common stock of the Company, today announced that it has delivered a letter to the Company's Chief Executive Officer, Mark Klein, and the members of the Company's Board of Directors.
Neptune Announces Closing of US$25.0 Million Underwritten Offering of Common Shares
CNW Group - Wed Mar 05, 8:11AM CST
Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.NTB), a biotechnology company engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids, announced today the closing of its previously announced public offering of 10,000,000 common shares at US$2.50 per common share for gross proceeds of US$25.0 million. Euro Pacific Canada Inc. and Roth Capital Partners, LLC acted as Joint Book-Running Managers for the offering and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD), acted as Lead Manager.
National Holdings Posts Fiscal 1st Quarter 2014 Results
Close-Up Media - Thu Feb 20, 11:32PM CST
National Holdings Corp., a full-service investment banking and asset management firm, announced financial results for the Company's fiscal first quarter ended December 31, 2013.
National Holdings Corporation Reports Fiscal First Quarter 2014 Results
Business Wire - Tue Feb 18, 7:00AM CST
National Holdings Corporation (OTCBB:NHLD) ("National Holdings" or the "Company"), a full-service investment banking and asset management firm, today announced financial results for the Company's fiscal first quarter ended December 31, 2013.
ZOFT Produces Custom Range of Sweet Candy Gifts for Sweethearts This Valentine's Day
M2 - Fri Feb 14, 3:12AM CST
ZOFT create Gum, Mints, Candy and Confections for suppliers around the world, and is offering heart-shaped special orders to help brands cash in when love is in the air.
National Holdings Corporation to Report Fiscal First Quarter 2014 Financial Results
Business Wire - Thu Feb 13, 7:00AM CST
National Holdings Corporation (OTC BB:NHLD) ("National Holdings" or the "Company") today announced that it will host a teleconference to discuss the Company's fiscal first quarter 2014 financial results at 10:00 a.m. ET on Tuesday, February 18, 2014. National Holdings will release its 2014 fiscal first quarter financial results prior to the market open on February 18, 2014.
Peregrine Pharmaceuticals Prices Offering of Its Series E Preferred Stock
Marketwire - Tue Feb 11, 7:03AM CST
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (the "Company"), announced today that it has priced an underwritten public offering of 700,000 shares of its 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a public offering price of $25.00 per share. Holders of Series E Preferred Stock may convert their shares, in whole or in part, into shares of the Company's common stock at a conversion price of $3.00 per share. Gross proceeds to the Company are expected to be approximately $17.5 million ($20.1 million if the option described below is exercised in full) before deducting the underwriting discount and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 19, 2014, subject to the satisfaction of customary closing conditions. The Company has also granted the underwriters an option to purchase up to an aggregate of 105,000 additional shares of its Series E Preferred Stock offered in the public offering, exercisable for 30 days. The Company intends to use the net proceeds from the offering for general corporate purposes. The Company has filed an application to list the shares of Series E Preferred Stock on the NASDAQ Capital Market under the symbol "PPHMP". If approved by NASDAQ, trading of the Series E Preferred Stock on the NASDAQ is expected to begin within 30 days after the date of initial issuance of the Series E Preferred Stock. MLV & Co. LLC is acting as sole book-runner. Maxim Group LLC and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (OTCBB: NHLD), are acting as lead managers for the offering and Empire Asset Management and I-Bankers Securities, Inc. are acting as co-managers for the offering. Roth Capital Partners, LLC and Piper Jaffray & Co. served as financial advisors to Peregrine.
Torchlight Energy Completes Equity Financing
Marketwire - Mon Feb 03, 7:01AM CST
Torchlight Energy Resources, Inc. (NASDAQ: TRCH) today announced that it has raised $5.6 million in a private placement offering of stock and warrants completed on January 31, 2014. National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc.(OTCBB: NHLD), was the sole placement agent. Proceeds from the offering will be used to fund its previously disclosed drilling programs.
Orchid Island Capital Announces Closing of Sale of Shares Pursuant to Full Exercise of Underwriters' Overallotment Option
GlobeNewswire - Wed Jan 29, 11:33AM CST
Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced today the closing of the sale of 270,000 shares of its common stock for net proceeds of $3,157,650 pursuant to the full exercise of the underwriters' overallotment option granted in connection with the Company's public offering that closed on January 23, 2014. All of the shares in the public offering, including the shares sold pursuant to the overallotment option, were offered by the Company. The shares are listed in the NYSE MKT under the symbol "ORC."
Tonix Pharmaceuticals Announces Closing of $43.5 Million Public Offering of Common Stock
GlobeNewswire - Wed Jan 29, 10:15AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 2,898,550 shares of its common stock. The shares were sold at the public offering price of $15.00 per share, bringing the aggregate gross proceeds from the offering to approximately $43.5 million, before deducting underwriting discounts and commissions and other offering expenses.
First flight from Abu Dhabi Pre-clearance facility marks sad day for U.S. airline industry
PR Newswire - Fri Jan 24, 5:12PM CST
Today marks a sad day for the U.S. airline industry, as the Southwest Airlines Pilots' Association (SWAPA) learned that the first flight from Abu Dhabi to the United States was operated utilizing the Customs and Border Patrol's Pre-Clearance facility located at the Abu Dhabi airport.
Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
GlobeNewswire - Fri Jan 24, 7:20AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the pricing of an underwritten public offering of 2,898,550 shares of its common stock at a price of $15.00 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 434,782 shares to cover overallotments in connection with the offering. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $40.7 million, assuming no exercise of the overallotment option. The offering is expected to close on January 29, 2014, subject to customary closing conditions.
Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire - Thu Jan 23, 3:02PM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Orchid Island Capital Closes Public Offering of Common Stock
GlobeNewswire - Thu Jan 23, 10:42AM CST
Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced that it closed its previously announced public offering of 1,800,000 shares of common stock at a public offering price of $12.50 per share earlier today. All of the shares in the public offering were offered by the Company. The shares are listed in the NYSE MKT under the symbol "ORC."
Orchid Island Capital Prices Public Offering of Common Stock
GlobeNewswire - Thu Jan 16, 4:59PM CST
Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced today the pricing of its public offering of 1,800,000 shares of common stock at $12.50 per share. The offering is expected to close on January 23, 2014. The Company has granted the underwriters a 30-day option to purchase up to an additional 270,000 shares of common stock on the same terms and conditions to cover over-allotments, if any. All of the shares in the public offering are being offered by the Company.
Full Circle Capital Corporation Prices Public Offering of Common Stock
Business Wire - Tue Jan 14, 8:12AM CST
Full Circle Capital Corporation (NASDAQ:FULL) ("Full Circle Capital"), today announced that it priced a public offering of 1,650,000 shares of its common stock at a public offering price of $7.13 per share for total gross proceeds of $11,764,500. Full Circle has also granted the underwriters a 30-day option to purchase up to 242,300 additional shares of common stock on the same terms and conditions to cover over-allotments, if any.
National Holdings Corporation to Reschedule Conference Call Regarding Fiscal 2013 Results Previously Announced on December 27, 2013
Business Wire - Thu Jan 09, 6:29AM CST
National Holdings Corporation (OTC BB: NHLD) ("National Holdings" or the "Company") today announced that it has postponed its fiscal year 2013 earnings update call originally scheduled for Thursday, January 9, 2014, at 9:00 AM ET.